IBDEI1EI ; ; 17-FEB-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,23811,1,3,0)
 ;;=3^HALOPERIDOL DECANOATE per 50MG
 ;;^UTILITY(U,$J,358.3,23812,0)
 ;;=J1050^^88^1013^7^^^^1
 ;;^UTILITY(U,$J,358.3,23812,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,23812,1,2,0)
 ;;=2^J1050
 ;;^UTILITY(U,$J,358.3,23812,1,3,0)
 ;;=3^MEDROXYPROGESTERONE ACETATE 1 MG
 ;;^UTILITY(U,$J,358.3,23813,0)
 ;;=J2315^^88^1013^8^^^^1
 ;;^UTILITY(U,$J,358.3,23813,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,23813,1,2,0)
 ;;=2^J2315
 ;;^UTILITY(U,$J,358.3,23813,1,3,0)
 ;;=3^NALTREXONE, DEPOT FORM 1 MG
 ;;^UTILITY(U,$J,358.3,23814,0)
 ;;=J2426^^88^1013^9^^^^1
 ;;^UTILITY(U,$J,358.3,23814,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,23814,1,2,0)
 ;;=2^J2426
 ;;^UTILITY(U,$J,358.3,23814,1,3,0)
 ;;=3^PALIPERIDONE PALMITATE EXTEND RELEASE 1 MG
 ;;^UTILITY(U,$J,358.3,23815,0)
 ;;=J2794^^88^1013^11^^^^1
 ;;^UTILITY(U,$J,358.3,23815,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,23815,1,2,0)
 ;;=2^J2794
 ;;^UTILITY(U,$J,358.3,23815,1,3,0)
 ;;=3^RISPERIDONE, LONG ACTING 0.5 MG
 ;;^UTILITY(U,$J,358.3,23816,0)
 ;;=J3420^^88^1013^14^^^^1
 ;;^UTILITY(U,$J,358.3,23816,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,23816,1,2,0)
 ;;=2^J3420
 ;;^UTILITY(U,$J,358.3,23816,1,3,0)
 ;;=3^VITAMIN B12 UP TO 1000 MCG
 ;;^UTILITY(U,$J,358.3,23817,0)
 ;;=96372^^88^1013^13^^^^1
 ;;^UTILITY(U,$J,358.3,23817,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,23817,1,2,0)
 ;;=2^96372
 ;;^UTILITY(U,$J,358.3,23817,1,3,0)
 ;;=3^TX PROPH OR DX INJ,SQ OR IM
 ;;^UTILITY(U,$J,358.3,23818,0)
 ;;=90472^^88^1013^5^^^^1
 ;;^UTILITY(U,$J,358.3,23818,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,23818,1,2,0)
 ;;=2^90472
 ;;^UTILITY(U,$J,358.3,23818,1,3,0)
 ;;=3^IMMUNIZATION ADMIN,EA ADDL VACCINE,IM
 ;;^UTILITY(U,$J,358.3,23819,0)
 ;;=90670^^88^1013^10^^^^1
 ;;^UTILITY(U,$J,358.3,23819,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,23819,1,2,0)
 ;;=2^90670
 ;;^UTILITY(U,$J,358.3,23819,1,3,0)
 ;;=3^PREVNAR 13 VACCINE IM
 ;;^UTILITY(U,$J,358.3,23820,0)
 ;;=86580^^88^1013^12^^^^1
 ;;^UTILITY(U,$J,358.3,23820,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,23820,1,2,0)
 ;;=2^86580
 ;;^UTILITY(U,$J,358.3,23820,1,3,0)
 ;;=3^TB INTRADERMAL TEST
 ;;^UTILITY(U,$J,358.3,23821,0)
 ;;=99411^^88^1014^1^^^^1
 ;;^UTILITY(U,$J,358.3,23821,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,23821,1,2,0)
 ;;=2^99411
 ;;^UTILITY(U,$J,358.3,23821,1,3,0)
 ;;=3^PREVENTIVE COUNSEL,GROUP,APPROX 30MIN
 ;;^UTILITY(U,$J,358.3,23822,0)
 ;;=99412^^88^1014^2^^^^1
 ;;^UTILITY(U,$J,358.3,23822,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,23822,1,2,0)
 ;;=2^99412
 ;;^UTILITY(U,$J,358.3,23822,1,3,0)
 ;;=3^PREVENTIVE COUNSEL,GROUP,APPROX 60MIN
 ;;^UTILITY(U,$J,358.3,23823,0)
 ;;=99401^^88^1014^3^^^^1
 ;;^UTILITY(U,$J,358.3,23823,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,23823,1,2,0)
 ;;=2^99401
 ;;^UTILITY(U,$J,358.3,23823,1,3,0)
 ;;=3^PREVENTIVE COUNSEL,INDIV,APPROX 15MIN
 ;;^UTILITY(U,$J,358.3,23824,0)
 ;;=99402^^88^1014^4^^^^1
 ;;^UTILITY(U,$J,358.3,23824,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,23824,1,2,0)
 ;;=2^99402
 ;;^UTILITY(U,$J,358.3,23824,1,3,0)
 ;;=3^PREVENTIVE COUNSEL,INDIV,APPROX 30MIN
 ;;^UTILITY(U,$J,358.3,23825,0)
 ;;=99404^^88^1014^6^^^^1
 ;;^UTILITY(U,$J,358.3,23825,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,23825,1,2,0)
 ;;=2^99404
 ;;^UTILITY(U,$J,358.3,23825,1,3,0)
 ;;=3^PREVENTIVE COUNSEL,INDIV,APPROX 60MIN
 ;;^UTILITY(U,$J,358.3,23826,0)
 ;;=99403^^88^1014^5^^^^1
 ;;^UTILITY(U,$J,358.3,23826,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,23826,1,2,0)
 ;;=2^99403
 ;;^UTILITY(U,$J,358.3,23826,1,3,0)
 ;;=3^PREVENTIVE COUNSEL,INDIV,APPROX 45MIN
